1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Adrenergic Receptor

Adrenergic Receptor

Beta Receptor

Adrenergic receptors are a class of G protein-coupled receptors that are targets of the catecholamines, especially norepinephrine and epinephrine. Many cells possess these receptors, and the binding of a catecholamine to the receptor will generally stimulate the sympathetic nervous system. The sympathetic nervous system is responsible for the fight-or-flight response, which includes widening the pupils of the eye, mobilizing energy, and diverting blood flow from non-essential organs to skeletal muscle. There are two main groups of adrenergic receptors, α and β, with several subtypes. α receptors have the subtypes α1 and α2. β receptors have the subtypes β1, β2 and β3. All three are linked to Gs proteins, which in turn are linked to adenylate cyclase. Agonist binding thus causes a rise in the intracellular concentration of the second messenger cAMP. Downstream effectors of cAMP include cAMP-dependent protein kinase (PKA), which mediates some of the intracellular events following hormone binding.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-176742
    ATR-258
    Agonist
    ATR-258 is a GRK2-biased β2AR partial agonist. ATR-258 is a competitive β1AR antagonist and shows weak partial agonist activity at β3AR at 10 μM. ATR-258 promotes glucose control and decreases lipid accumulation in obese mice with reduced side effects. ATR-258 can be used for T2DM research.
    ATR-258
  • HY-15746B
    Dobutamine tartrate
    Agonist
    Dobutamine tartrate is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine tartrate is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine tartrate can increase cardiac output and correct hypoperfusion.
    Dobutamine tartrate
  • HY-105124S
    Bufuralol-d9 hydrochloride
    Bufuralol-d9 (hydrochloride) is the deuterium labeled Bufuralol hydrochloride.
    Bufuralol-d<sub>9</sub> hydrochloride
  • HY-116790BS
    (±)-Penbutolol-d9
    (±)-Penbutolol-d9 is the deuterium labeled (±)-Penbutolol.
    (±)-Penbutolol-d<sub>9</sub>
  • HY-17497S1
    Acebutolol-d5
    Acebutolol-d5 is the deuterium labeled Acebutolol.
    Acebutolol-d<sub>5</sub>
  • HY-B0006S
    Carvedilol-d3
    Inhibitor
    Carvedilol-d3 is the deuterium labeled Carvedilol. Carvedilol (BM 14190) is a non-selective β/α-1 blocker. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome.
    Carvedilol-d<sub>3</sub>
  • HY-A0019S
    Paliperidone-d4
    Antagonist
    Paliperidone-d4 is the deuterium labeled Paliperidone. Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia.
    Paliperidone-d<sub>4</sub>
  • HY-B0573CS
    (R)-Propranolol-d7
    (R)-Propranolol-d7 is the deuterium labeled (R)-Propranolol.
    (R)-Propranolol-d<sub>7</sub>
  • HY-17503S2
    (S)-Metoprolol-d7
    Inhibitor
    (S)-Metoprolol-d7 is the deuterium labeled Metoprolol. Metoprolol (Toprol) is a selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension[1][2].
    (S)-Metoprolol-d<sub>7</sub>
  • HY-17498AS
    (S)-Atenolol-d7
    (S)-Atenolol-d7 is the deuterium labeled (S)-Atenolol.
    (S)-Atenolol-d<sub>7</sub>
  • HY-B0431AS
    Phenoxybenzamine-d5 hydrochloride
    Antagonist
    Phenoxybenzamine-d5 (hydrochloride) is the deuterium labeled Phenoxybenzamine hydrochloride. Phenoxybenzamine hydrochloride is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine hydrochloride also shows antitumor activity[1][2][3].
    Phenoxybenzamine-d<sub>5</sub> hydrochloride
  • HY-110223
    Atomoxetine-d3 hydrochloride
    Inhibitor
    Atomoxetine-d3 hydrochloride is the deuterium labeled Atomoxetine hydrochloride. Atomoxetine hydrochloride is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively).
    Atomoxetine-d3 hydrochloride
  • HY-B0192AS
    Alfuzosin-d3 hydrochloride
    Antagonist
    Alfuzosin-d3 hydrochloride is the deuterium labeled Alfuzosin hydrochloride. Alfuzosin hydrochloride is an α1 adrenergic receptor antagonist used to treat benign prostatic hyperplasia (BPH).
    Alfuzosin-d<sub>3<sub> hydrochloride
  • HY-17503S1
    (R)-Metoprolol-d7
    Inhibitor
    (R)-Metoprolol-d7 is the deuterium labeled Metoprolol. Metoprolol (Toprol) is a selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension[1][2].
    (R)-Metoprolol-d<sub>7</sub>
  • HY-119873S
    Celiprolol-d9 hydrochloride
    Celiprolol-d9 (hydrochloride) is the deuterium labeled Celiprolol hydrochloride.
    Celiprolol-d<sub>9</sub> hydrochloride
  • HY-B1110S
    Nomifensine-d3 maleate
    Inhibitor
    Nomifensine-d3 ((±)-Nomifensine-d3) maleate is the deuterium labeled Nomifensine maleate (HY-B1110A). Nomifensine ((±)-Nomifensine) maleate is a potent norepinephrine (NE) and dopamine (DA) reuptake inhibitor. Nomifensine maleate inhibits uptake of NE, DA and 5-HT in rat brain synaptosomes, with IC50 values of 6.6 nM, 48 nM and 830 nM, and Ki values of 4.7 nM, 26 nM and 4000 nM, respectively. Nomifensine maleate has antidepressant and analgesic effects. Nomifensine maleate is used in neurodegenerative diseases, compound addiction, and pain research.
    Nomifensine-d<sub>3</sub> maleate
  • HY-118335S
    Prazobind-d8
    Prazobind-d8 is the deuterium labeled Prazobind (HY-118335). Prazobind (SZL 49), a prazosin analog, is a selective α1-adrenoceptor antagonist. Prazobind competes for alpha 1-adrenoceptor binding sites with a similar potency (IC50 of 1 nM) in tissues enriched in both the alpha 1A (hippocampus) and alpha 1B (liver) subtypes. Prazobind can be used for the study of blood pressure.
    Prazobind-d8
  • HY-12721S
    Clonidine-d4 hydrochloride
    Agonist
    Clonidine-d4 (hydrochloride) is the deuterium labeled Clonidine. Clonidine hydrochloride is an alpha 2-adrenergic agonist.
    Clonidine-d<sub>4</sub> hydrochloride
  • HY-17034BS
    Medetomidine-d3 hydrochloride
    Agonist
    Medetomidine-d3 (hydrochloride) is the deuterium labeled Medetomidine hydrochloride. Medetomidine hydrochloride is an agonist of adrenergic alpha-2 receptor.
    Medetomidine-d<sub>3</sub> hydrochloride
  • HY-B0661CS
    (Rac)-Tamsulosin-d3 hydrochloride
    (Rac)-Tamsulosin-d3 (hydrochloride) is the deuterium labeled (Rac)-Tamsulosin hydrochloride.
    (Rac)-Tamsulosin-d<sub>3</sub> hydrochloride
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.